A Look At CBIZ (CBZ) Valuation After Lawsuit Over AmeriTex Holdings Appraisal Moves Forward

CBIZ (CBZ) is back in focus after a federal judge rejected its bid to halt a lawsuit over an allegedly understated valuation of AmeriTex Holdings, allowing full discovery into claimed intentional breaches of duty.

See our latest analysis for CBIZ.

Despite the legal setback, CBIZ’s share price has struggled for some time, with a 90 day share price return of 50.62% and a 1 year total shareholder return of 65.15%, signaling fading momentum rather than a short term wobble.

If this kind of legal and business complexity has you looking further afield, it could be a good moment to broaden your search with 20 top founder-led companies

With CBIZ trading at US$26.13 and an analyst price target of US$50.00, plus an estimated intrinsic discount of about 57%, is this a mispriced risk or a stock where the market already sees the future?

Most Popular Narrative: 47.7% Undervalued

With CBIZ’s fair value in the most followed narrative set at $50 versus a last close of $26.13, the story hinges on how the business scales from here.

The Marcum acquisition has significantly expanded CBIZ's client base, increased scale, and strengthened capabilities in core tax, accounting, and advisory services, enabling the firm to leverage cross-selling, deepen client relationships, and improve its competitive position in target middle-market segments; this is expected to fuel higher future revenue growth and structural margin expansion as integration synergies are realized.

Read the complete narrative.

Curious what kind of revenue runway, margin lift, and future earnings multiple need to line up to support that $50 fair value? The narrative leans on a specific blend of top line growth, profitability targets, and a re rated valuation that may surprise you once you see the full set of assumptions behind it.

Result: Fair Value of $50 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, that $50 fair value hinges on pricing holding up and Marcum integrating cleanly, and both pressure on rates and acquisition hiccups could weaken the story.

Find out about the key risks to this CBIZ narrative.

Next Steps

The mix of legal risks and potential opportunities here is significant, so it makes sense to act promptly and verify the numbers for yourself, including the 4 key rewards and 3 important warning signs

Ready to scout your next opportunity?

If CBIZ feels complex, do not stall on your research. Put that curiosity to work and let a focused screener surface ideas you might otherwise miss.

• Target stronger balance sheets by scanning companies that pass strict debt and liquidity checks using the solid balance sheet and fundamentals stocks screener (39 results).
• Hunt for potential value opportunities where price and fundamentals look out of sync with the 62 high quality undervalued stocks.
• Spot under the radar names with healthy financials before they are widely talked about through the screener containing 25 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com